INDBInternet News Database 2.5 Updated just now · 297 sources Show or hide images Light or dark

Results for “Tirzepatide Linked”

Health
2 sources

Who is covering this

Google NewsCenterMedscapeCenter
Truth score 50
Centre 100%100%
Google NewsCenter

After a GLP-1: Which Exit Strategy Keeps the Weight Off?

After a GLP-1: Which Exit Strategy Keeps the Weight Off? Medscape Taking GLP-1s forever? 5 strategies to keep weight off if you stop American Council on Science and Health Switching Between Semaglutide and Tirzepatide Linked to 16%...

Lean: Center Fact-focusedFactuality: HighCountry: United StatesFunding: Corporate
  • Medscape After a GLP-1: Which Exit Strategy Keeps the Weight Off?

    After a GLP-1, what works next? Among more than 20,000 patients, surgery was linked to the most weight loss, quitting cold the least, and switching from semaglutide to tirzepatide beat staying put. Medscape Medical News

    Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent50%
Google News50%
Avg reliability70
Low-credibility share0%
Fact / opinion2/0
State media0%
More analysis
Truth score: 50 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 2 Reliability: 70 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 3 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

MedpagetodayCenter
Truth score 38
Centre 100%100%
MedpagetodayCenter

Tirzepatide Cuts BMI in Adolescents With Obesity in Phase III Trial

(MedPage Today) -- NATIONAL HARBOR, Md. -- Tirzepatide (Zepbound) yielded substantial reductions in BMI among adolescents with obesity or overweight with obesity-related complications, the phase III SURMOUNT-ADOLESCENTS trial showed. At week...

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Like
Health
1 source

Who is covering this

MedscapeCenter
Truth score 38
Centre 100%100%
MedscapeCenter

Tirzepatide Plus Online Support: Health Gains, Lower Costs

Adding online support to tirzepatide was projected to lead to greater health gains than the drug alone, assuming no extra cost, in a UK model of adults with obesity. Medscape Medical News

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: 100Sensationalism: 0 Amplification: 0

How we score

Like